Dr. Mitchell Grayson, MD

NPI: 1720005267
Total Payments
$48,093
2024 Payments
$1,280
Companies
11
Transactions
37

Payment Breakdown by Category

Consulting$44,888 (93.3%)
Travel$2,063 (4.3%)
Food & Beverage$1,142 (2.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $44,888 15 93.3%
Travel and Lodging $2,063 9 4.3%
Food and Beverage $1,142 13 2.4%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $8,625 6 $0 (2018)
GlaxoSmithKline, LLC. $7,806 5 $0 (2021)
Merck Sharp & Dohme Corporation $7,365 2 $0 (2021)
AbbVie Inc. $6,613 1 $0 (2021)
Genentech, Inc. $4,931 6 $0 (2018)
Bayer Healthcare LLC $3,153 1 $0 (2023)
GENZYME CORPORATION $3,148 3 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $3,146 2 $0 (2024)
AstraZeneca UK Limited $3,104 8 $0 (2018)
Genentech USA, Inc. $141.03 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,280 2 Bayer Healthcare Pharmaceuticals Inc. ($1,170)
2023 $5,129 2 Bayer Healthcare LLC ($3,153)
2021 $17,246 7 Merck Sharp & Dohme Corporation ($7,365)
2020 $4,250 1 GlaxoSmithKline, LLC. ($4,250)
2019 $3,048 2 GENZYME CORPORATION ($3,020)
2018 $17,000 21 Novartis Pharmaceuticals Corporation ($8,598)
2017 $139.99 2 Genentech USA, Inc. ($112.50)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/26/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $110.32 General
Category: Immunology
06/07/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Consulting Fee Cash or cash equivalent $1,170.00 General
Category: Womens Health
12/01/2023 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Consulting Fee Cash or cash equivalent $1,976.00 General
Category: Womens Health
06/09/2023 Bayer Healthcare LLC Essure (Device) Consulting Fee Cash or cash equivalent $3,152.50 General
Category: Womens Health
11/30/2021 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $650.00 General
11/12/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,627.50 General
11/07/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.45 General
Category: Immunology
10/21/2021 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $6,612.50 General
Category: IMMUNOLOGY
08/03/2021 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $650.00 General
07/07/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $5,737.50 General
04/13/2021 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $1,950.00 General
09/21/2020 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $4,250.00 General
11/07/2019 Genentech USA, Inc. Food and Beverage In-kind items and services $28.53 General
08/12/2019 GENZYME CORPORATION DUPIXENT (Drug) Consulting Fee Cash or cash equivalent $3,019.50 General
Category: IMMUNOLOGY
12/01/2018 Genentech, Inc. Xolair (Biological) Food and Beverage In-kind items and services $434.07 General
Category: Immunology
11/30/2018 Genentech, Inc. Xolair (Biological) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: Immunology
11/30/2018 Genentech, Inc. Xolair (Biological) Travel and Lodging In-kind items and services $797.83 General
Category: Immunology
11/30/2018 Genentech, Inc. Xolair (Biological) Travel and Lodging In-kind items and services $421.20 General
Category: Immunology
11/30/2018 Genentech, Inc. Xolair (Biological) Food and Beverage Cash or cash equivalent $44.41 General
Category: Immunology
11/30/2018 Genentech, Inc. Xolair (Biological) Travel and Lodging Cash or cash equivalent $33.00 General
Category: Immunology
11/14/2018 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Consulting Fee Cash or cash equivalent $7,886.00 General
Category: RESPIRATORY
11/14/2018 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Travel and Lodging In-kind items and services $410.92 General
Category: RESPIRATORY
11/14/2018 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Food and Beverage In-kind items and services $128.19 General
Category: RESPIRATORY
11/14/2018 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Travel and Lodging In-kind items and services $118.00 General
Category: RESPIRATORY
11/14/2018 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Travel and Lodging Cash or cash equivalent $54.48 General
Category: RESPIRATORY

About Dr. Mitchell Grayson, MD

Dr. Mitchell Grayson, MD is a Allergy & Immunology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720005267.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Grayson, MD has received a total of $48,093 in payments from pharmaceutical and medical device companies, with $1,280 received in 2024. These payments were reported across 37 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($44,888).

Practice Information

  • Specialty Allergy & Immunology
  • Other Specialties Pediatric Allergy/Immunology
  • Location Columbus, OH
  • Active Since 07/17/2006
  • Last Updated 02/15/2022
  • Taxonomy Code 207RA0201X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1720005267

Products in Payments

  • XOLAIR (Biological) $8,625
  • RINVOQ (Biological) $6,613
  • Essure (Device) $6,299
  • Xolair (Biological) $5,043
  • DUPIXENT (Drug) $3,020
  • ANORO (Drug) $306.00
  • DUPIXENT (Biological) $128.77
  • ORALAIR (Biological) $62.06

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy & Immunology Doctors in Columbus